Company Filing History:
Years Active: 2013
Title: Jon Meigh: Innovator in Pharmaceutical Compounds
Introduction
Jon Meigh is a notable inventor based in Manchester, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 2-pyridone compounds. His research focuses on developing compounds that have therapeutic applications, specifically as inhibitors of human neutrophil elastase.
Latest Patents
Jon Meigh holds a patent for 2-pyridone compounds. The invention provides compounds of a specific formula, wherein R, R, R, R, R, R, L, X, and Y are defined in the specification. This patent also includes processes and intermediates for the preparation of these compounds, as well as pharmaceutical compositions containing them and their use in therapy.
Career Highlights
Jon Meigh is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative therapies that address critical health issues.
Collaborations
Throughout his career, Jon has collaborated with several talented individuals, including Andiappan Murugan and Lena Kristina Bergstrom. These collaborations have enhanced the research and development of pharmaceutical compounds.
Conclusion
Jon Meigh's contributions to the field of pharmaceuticals through his patent on 2-pyridone compounds exemplify his innovative spirit and dedication to improving health outcomes. His work continues to influence the development of new therapeutic options.